<DOC>
	<DOCNO>NCT01718587</DOCNO>
	<brief_summary>The current treatment method liver cirrhosis limit , include antiviral therapy , supportive therapy liver transplantation . Antiviral therapy Supportive therapy especially regularly intravenous infusion plasma albumin combine clinical classical therapy treatment . In hand , umbilical cord mesenchyma stem cell self direct differentiation capacity effectively rescue experimental liver failure contribute liver regeneration , suggest feasibility stem cell transplantation therapy . In study , safety efficacy umbilical cord mesenchyma stem cell transplantation interventional procedure classical therapy patient liver cirrhosis evaluate compare .</brief_summary>
	<brief_title>Difference Efficacy Between Stem Cell Transplantation Classical Therapy Liver Cirrhosis Patients</brief_title>
	<detailed_description>This study includ two research center , number patient transplantation group 30 , number patient classical therapy group 30 . All inclusion exclusion criterion data analysis complete epidemiological commissioner .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Clinical diagnosis liver cirrhosis ; Without hepatic encephalopathy ; No ascites easily dissipate ascites ; Value bilirubin less 100 ; Value albumin great 16 g / L ; Prothrombin time le 21 second ; Severe cardiovascular disease , immunocompromised patient ; Patients localize lesion affect graft infection ; Coagulation disorder ; Liver nodules 2cm Liver cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>umbilical cord mesenchyma stem cell</keyword>
	<keyword>liver cirrhosis</keyword>
	<keyword>antiviral therapy</keyword>
</DOC>